Riyadh, KSA: Clinicy, an innovative Saudi healthtech business has announced a successful seven-figure investment from Riyadh-headquartered private equity firm Mad’a Investment Company. The funding follows successful integration and implementation results with medical institutions. The proprietary healthcare management system manages bookings, appointments and patient engagement, increasing efficiency and quality of service. While the exact investment figure remains undisclosed, it is the largest Pre-Series A investment in the healthtech sector in the Kingdom of Saudi Arabia this year.
On the occasion of the investment round signing, Clinicy Co-founder and Managing Director, Talal Waleed Al-Hussein said, “This investment will allow us to scale the number of medical institutions and patients using Clinicy and further support our vital healthcare sector. We are proud that Mad’a Investment Company has confidence in Clinicy’s successful model. Through this strategic partnership we will be able to capitalize on expertise and knowledge as we continue the development of quality innovative solutions and services. Our expansion will help to reach a larger segment of customers and focus on creating enhanced experiences and benefits for users.”
Mad’a Investment Company CEO, Abdullah Abdulaziz Al-Othaim said, “In line with Vision 2030 goals to improve the quality and efficiency of the health sector, Clinicy has demonstrated a valuable proposition which has the power to transform and enhance healthcare services across the entire region. As we have all seen over the past year during the pandemic, healthcare is one of the most important sectors for society. We are pleased to invest in a homegrown Saudi startup that provides excellence in digitizing healthcare management and is a first-of-its-kind in the Kingdom. This investment adds to our commitment in supporting businesses that create jobs through innovation.”
This latest round continues Mad’a Investment Company’s commitment in supporting the healthcare sector, with 121 health professionals already employed through the private equity firm’s strategic investments.
After 24 months of research and development, Clinicy identified three core challenges: missed appointments (no-show), high administrative operating costs and lack of reach and communication with patients. The average local market ‘no-show’ rate of patients who fail to attend appointments is over 30 per cent, costing more than 2.2billion Saudi Riyals (USD $600mn) annually. This rate hasn’t changed in two decades.
Clinicy addresses each of these challenges with its proprietary patient engagement system, seamlessly managing daily operations including automating bookings and appointments between medical institutions and patients. Its integration with clinics across the Kingdom has been highly successful, including reducing ‘no-show’ rates by up to 40 per cent, 61 per cent of interactions with patients automated via the Clinicy communication tool and a 30 per cent reduction in daily tasks for call center, receptionists and coordinators.
For further information about Mad’a Investment Company, please visit www.minvest.sa
For more information about Clinicy, please visit www.clinicy.com.sa
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
